KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Convertible Debt (2017 - 2022)

Historic Convertible Debt for Silicon Laboratories (SLAB) over the last 6 years, with Q4 2022 value amounting to $529.6 million.

  • Silicon Laboratories' Convertible Debt changed N/A to $529.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $529.6 million, marking a year-over-year change of. This contributed to the annual value of $529.6 million for FY2022, which is N/A changed from last year.
  • Per Silicon Laboratories' latest filing, its Convertible Debt stood at $529.6 million for Q4 2022.
  • In the past 5 years, Silicon Laboratories' Convertible Debt ranged from a high of $571.8 million in Q3 2020 and a low of $345.0 million during Q1 2018
  • Moreover, its 5-year median value for Convertible Debt was $428.9 million (2021), whereas its average is $432.7 million.
  • In the last 5 years, Silicon Laboratories' Convertible Debt soared by 5819.77% in 2020 and then tumbled by 2310.7% in 2021.
  • Silicon Laboratories' Convertible Debt (Quarter) stood at $354.8 million in 2018, then grew by 3.8% to $368.3 million in 2019, then surged by 52.52% to $561.7 million in 2020, then fell by 20.75% to $445.1 million in 2021, then rose by 18.98% to $529.6 million in 2022.
  • Its Convertible Debt stands at $529.6 million for Q4 2022, versus $529.1 million for Q4 2022 and $528.6 million for Q3 2022.